Document is current
Any future updates will be listed below
-
Authors
Goldberg, Gregory W. https://orcid.org/0000-0002-5022-9976
Spencer, Jeffrey M.
Giganti, David O.
Camellato, Brendan R.
Agmon, Neta
Ichikawa, David M.
Boeke, Jef D. https://orcid.org/0000-0001-5322-4946
Noyes, Marcus B.
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R01GM118851, F32GM137482)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences
- License Information
-
More Information
Article History
Received: 27 March 2020
Accepted: 18 November 2020
First Online: 13 January 2021
Competing interests
: Jef Boeke is a Founder and Director of CDI Labs, Inc., a Founder of Neochromosome, Inc, a Founder and SAB member of ReOpen Diagnostics, and serves or served on the Scientific Advisory Board of the following: Sangamo, Inc., Modern Meadow, Inc., Sample6, Inc. and the Wyss Institute. New York University is pursuing patent protection for the findings described in this work; a provisional patent application has been filed with the U.S. Patent and Trademark Office with Marcus Noyes and Gregory Goldberg as inventors. The other authors declare no competing interests.
